Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 35 - Issue 9 - September, 2023

Feature

Clinical Images
Extraction of an Entangled Coronary Guidewire Using the Balloon Trapping Technique
09/24/2023

Asad Shabbir MD1, Pablo Zulet MD1, Javier Escaned MD PhD1, Hernán Mejía-Rentería MD PhD1

Asad Shabbir MD1, Pablo Zulet MD1, Ja...
A 74-year-old man who previously underwent percutaneous coronary intervention (PCI) for a right coronary non-ST-segment elevation myocardial infarction was scheduled for physiology-guided PCI to a left main stem (LMS)/left anterior descending...
A 74-year-old man who previously underwent percutaneous coronary intervention (PCI) for a right coronary non-ST-segment elevation myocardial infarction was scheduled for physiology-guided PCI to a left main stem (LMS)/left anterior descending...
A 74-year-old man who previously...
09/24/2023
Journal of Invasive Cardiology
Case Series
A Case Series of Novel Technique of Coronary Protection for Patients With Low Coronary Height Undergoing Transcatheter Aortic Valve Implantation
09/18/2023

Mohammad Alkhalil1,2;Amjad Ghazal Asswad1; Mohamed Farag1; Azfar Zaman1,2

Mohammad Alkhalil1,2;Amjad Ghazal Ass...
Coronary artery occlusion (CAO) in patients undergoing transcatheter aortic valve implantation (TAVI) is rare but is associated with up to 50% mortality risk. We report a case series of a novel technique of coronary protection for patients...
Coronary artery occlusion (CAO) in patients undergoing transcatheter aortic valve implantation (TAVI) is rare but is associated with up to 50% mortality risk. We report a case series of a novel technique of coronary protection for patients...
Coronary artery occlusion (CAO)...
09/18/2023
Journal of Invasive Cardiology
Original Contribution
Coronary Procedures via Distal Transradial Access in Older as Compared With Non-Older Patients: Insights From the DISTRACTION Registry
09/15/2023

Marcos Danillo Oliveira, MD, MSc1,2; Ednelson Cunha Navarro, MD2; Nathalia Rodrigues Branca, MD³; Maria Eduarda Garcia, MD³; Maria Clara Scarpa, MD³; Adriano Caixeta, MD, PhD1,4

Marcos Danillo Oliveira, MD, MSc1,2; ...
Older patients are at a higher risk of access site complications and bleeding. Systematic reviews and meta-analysis have highlighted the benefits of distal over proximal transradial access (mainly, lower rates of radial artery occlusion and...
Older patients are at a higher risk of access site complications and bleeding. Systematic reviews and meta-analysis have highlighted the benefits of distal over proximal transradial access (mainly, lower rates of radial artery occlusion and...
Older patients are at a higher...
09/15/2023
Journal of Invasive Cardiology
Original Contribution
Impact of Target Vessel on the Procedural Techniques and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention
09/13/2023

Spyridon Kostantinis, MD1, Athanasios Rempakos, MD1, Bahadir Simsek, MD1, Judit Karacsonyi, MD, PhD1, Salman S Allana, MD1, Khaldoon Alaswad, MD2, Mir Babar Basir, MD2, Rhian E Davies, DO3, Stewart M Benton Jr, MD3, Oleg Krestyaninov,MD4, Dmitrii Khelimskii, MD4, Wissam A Jaber, MD5, Stephane Rinfret, MD5, William Nicholson, MD5, Jarrod Frizzell, MD6, Farouc A Jaffer, MD, PhD7, Jaikirshan J Khatri, MD8, Paul Poommipanit, MD9, James W Choi, MD10, Raj Chandwaney, MD11, Brian K Jefferson, MD12, Taral N Patel, MD12, Karim M Al-Azizi, MD13, Srinivasa Potluri, MD13, Nazif Aygul, MD14, Ahmed M ElGuindy, MD15, Nidal Abi Rafeh, MD16, Omer Goktekin, MD17, Michaella Alexandrou, MD1, Olga C Mastrodemos, BA1, Bavana V Rangan, BDS, MPH1, Yader Sandoval, MD1, M Nicholas Burke, MD1, Emmanouil S Brilakis, MD, PhD1, Sevket Gorgulu, MD18

Spyridon Kostantinis, MD1, Athanasios...
There is limited information on the impact of the target vessel on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We analyzed the baseline clinical and angiographic...
There is limited information on the impact of the target vessel on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We analyzed the baseline clinical and angiographic...
There is limited information on...
09/13/2023
Journal of Invasive Cardiology
Original Contribution
Aortic Luminal Remodeling After Intravascular Stent Therapy for Coarctation of the Aorta: Intermediate Results
09/13/2023

Louise Pei, BSc, Msc1,2,*; Lusine Abrahamyan, MD, MPH, PhD2,3,*; Jaime C Sklar, MD, MSc1,4; Annamalar Muthuppalaniappan, MBBS, MRCP5; Ricardo Gorocica Romero, MD6; Lee Benson, MD7; Mark Osten, MD, FRCPC7; Eric M Horlick, MDCM1,7

Louise Pei, BSc, Msc1,2,*; Lusine Abr...
Outcomes after adult coarctation of the aorta (CoA) stenting is scant. We explored predictors of aortic remodeling after stent implantation and report early- and intermediate-term clinical outcomes.
Outcomes after adult coarctation of the aorta (CoA) stenting is scant. We explored predictors of aortic remodeling after stent implantation and report early- and intermediate-term clinical outcomes.
Outcomes after adult coarctation...
09/13/2023
Journal of Invasive Cardiology
Case Report
Adverse Events With Intravascular Lithotripsy After Coronary Use: A Report From the FDA MAUDE Database
08/30/2023

Athanasios Rempakos1, MD; Bahadir Simsek1, MD; Spyridon Kostantinis1, MD; Michaella Alexandrou1, MD; Judit Karacsonyi1, MD, PhD; Bavana V. Rangan1, BDS, MPH; Olga C. Mastrodemos1, BA; Salman S Allana1, MD; Yader Sandoval1, MD; M. Nicholas Burke1, MD, Emmanouil S. Brilakis1, MD, PhD

Athanasios Rempakos1, MD; Bahadir Sim...
Percutaneous coronary intervention (PCI) on heavily calcified lesions has been associated with more complications.1 Intravascular lithotripsy (IVL) was recently approved for treating de novo calcified coronary lesions based on excellent...
Percutaneous coronary intervention (PCI) on heavily calcified lesions has been associated with more complications.1 Intravascular lithotripsy (IVL) was recently approved for treating de novo calcified coronary lesions based on excellent...
Percutaneous coronary...
08/30/2023
Journal of Invasive Cardiology
Clinical Images
A Tale of Tears and Healing
08/28/2023

Visvesh Jeyalan1, Vamsidhar Dronavalli1, Azfar Zaman1, Mohammad Alkhalil1,2

Visvesh Jeyalan1, Vamsidhar Dronavall...
A 78-year-old woman with a background of hypertension and osteoarthritis presented with a history of syncope secondary to severe aortic stenosis. She underwent a computed tomography (CT) scan that showed a heavily calcific trileaflet aortic...
A 78-year-old woman with a background of hypertension and osteoarthritis presented with a history of syncope secondary to severe aortic stenosis. She underwent a computed tomography (CT) scan that showed a heavily calcific trileaflet aortic...
A 78-year-old woman with a...
08/28/2023
Journal of Invasive Cardiology
Case Report
Quadricuspid Aortic Valve
08/28/2023

Akash Jain, MD1; Jayashree Kharge, MD, DM1; Cholanahalli Nanjappa Manjunath, MD, DM1; Yamasandi Siddegowda Shrimanth, MD, DM2

Akash Jain, MD1; Jayashree Kharge, MD...
A 56-year-old man presented with typical angina for 1 day and a prior history of exertional  dyspnea of 6 months duration. Clinically, he was diagnosed with severe aortic regurgitation (AR). Electrocardiogram showed left ventricular...
A 56-year-old man presented with typical angina for 1 day and a prior history of exertional  dyspnea of 6 months duration. Clinically, he was diagnosed with severe aortic regurgitation (AR). Electrocardiogram showed left ventricular...
A 56-year-old man presented with...
08/28/2023
Journal of Invasive Cardiology
Original Contribution
Improving Patient Outcomes with a Mobile Digital Health Platform for Patients Undergoing Transcatheter Aortic Valve Replacement
08/10/2023

Vishal Venkatraman, MHSc1; Shivanand P. Lad, MD, PhD1; Ziad F. Gellad, MD, MPH2; Helen Heo, BS; Kevin A. Wu, BS; Rajeev Dharmapurikar MS2; Beiyu Liu, PhD3; Sin-Ho Jung, PhD3; Ryan Plichta, MD4; J. Kevin Harrison, MD5; Tom C. Nguyen, MD 6; Julie Doberne, MD, PhD4

 

Vishal Venkatraman, MHSc1; Shivanand ...
ManageMySurgery (MMS) is a digital health application (app) for patients undergoing surgery, including Transcatheter Aortic Valve Replacement (TAVR). Patients using MMS review procedure-specific education, view FAQs, and report...
ManageMySurgery (MMS) is a digital health application (app) for patients undergoing surgery, including Transcatheter Aortic Valve Replacement (TAVR). Patients using MMS review procedure-specific education, view FAQs, and report...
ManageMySurgery (MMS) is a...
08/10/2023
Journal of Invasive Cardiology
Clinical Images
Percutaneous Edge-to-Edge Repair as a Bailout Option to Treat Iatrogenic Leaflet Perforation
08/28/2023

Andrea Fisicaro, MD1; Daniela Mele, MD1; Enrico Fabris MD, PhD2, Francesco Giannini, MD1,3

Andrea Fisicaro, MD1; Daniela Mele, M...
An 80-year-old man was referred to our center for heart failure and severe degenerative mitral regurgitation (MR). Transesophageal echocardiography revealed severe MR due to anterior leaflet prolapse, mainly in its central portion (A2) in the...
An 80-year-old man was referred to our center for heart failure and severe degenerative mitral regurgitation (MR). Transesophageal echocardiography revealed severe MR due to anterior leaflet prolapse, mainly in its central portion (A2) in the...
An 80-year-old man was referred...
08/28/2023
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

September 2023 Volume 35 Issue 9

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement